Demographics
|
Age: median (IQR)
|
54 (40–65)
|
60 (47–67)
|
64 (53–75)
|
0.002
|
Sex: female
|
51 (48%)
|
30 (44%)
|
36 (49%)
|
0.79
|
White
|
68 (64%)
|
41 (59%)
|
53 (72%)
|
0.30
|
Black
|
30 (28%)
|
16 (23%)
|
16 (22%)
|
0.55
|
Asian/East Indian
|
2 (2%)
|
6 (9%)
|
2 (3%)
|
0.06
|
Hispanic
|
4 (4%)
|
5 (7%)
|
3 (4%)
|
0.54
|
Other or unrecorded
|
2 (2%)
|
1 (1%)
|
0
|
0.51
|
Blood culture result
|
1. No blood culture done or blood culture negative
|
100 (94%)
|
11 (16%)
|
66 (89%)
|
< 0.001
|
2. Blood culture positive
|
3 (3%)
|
29 (42%)
|
4 (5%)
|
< 0.001
|
3. Gram positive
|
3 (3%)
|
13 (19%)
|
3 (4%)
|
< 0.001
|
4. Gram negative
|
0
|
11 (16%)
|
1 (1%)
|
< 0.001
|
5. Mixed Gram pos/neg
|
0
|
5 (7%)
|
0
|
0.001
|
6. Fungus
|
0
|
0
|
0
|
NA
|
Infection site
|
Respiratory tract (non-lung)
|
0
|
3 (4%)
|
4 (5%)
|
0.06
|
Lung (pneumonia)
|
3 (3%)
|
15 (22%)
|
24 (32%)
|
< 0.001
|
Abdominal
|
0
|
10 (14%)
|
2 (3%)
|
< 0.001
|
Urinary tract
|
0
|
8 (12%)
|
3 (4%)
|
0.001
|
Other site
|
0
|
21 (30%)
|
4 (5%)
|
< 0.001
|
Not identified
|
103 (97%)
|
12 (17%)
|
37 (50%)
|
< 0.001
|
Clinical parameters, outcome
|
Days in hospital: median (IQR)
|
3 (2–5)
|
8 (5–14)3
|
6 (4–9)
|
< 0.001
|
Days in ICU: median (IQR)
|
2 (1–2)
|
3 (2–5)
|
2 (1–4)
|
0.002
|
Antibiotics given in ICU
|
60 (57%)
|
68 (99%)
|
68 (92%)
|
< 0.001
|
APACHE score: median (IQR)2
|
54 (29–84)
|
76 (46–95)3
|
82 (48–103)4
|
< 0.001
|
SOFA score: median (IQR)
|
4 (2–7)6
|
5 (4–10)5
|
6 (4–8)7
|
0.02
|
Mortality
|
6 (6%)
|
9 (13%)3
|
9 (12%)
|
0.18
|